HCID 11568520, 화합물 → HCID 178511292, 화합물

HRID 422635노트

반응식

HRID 422635 반응식
[N:1]([CH2:4][CH:5]1[CH2:8][CH:7]([C:9]2[N:13]3[CH:14]=[CH:15][N:16]=[C:17]([NH2:18])[C:12]3=[C:11]([C:19]3[CH:28]=[C:27]4[C:22]([CH:23]=[CH:24][C:25]([C:29]5[CH:34]=[CH:33][CH:32]=[CH:31][CH:30]=5)=[N:26]4)=[CH:21][CH:20]=3)[N:10]=2)[CH2:6]1)=[N+]=[N-]>C(O)C.[Pd].CC([O-])=O.CC([O-])=O.[Pb+2]>[NH2:1][CH2:4][C@@H:5]1[CH2:6][C@H:7]([C:9]2[N:13]3[CH:14]=[CH:15][N:16]=[C:17]([NH2:18])[C:12]3=[C:11]([C:19]3[CH:28]=[C:27]4[C:22]([CH:23]=[CH:24][C:25]([C:29]5[CH:34]=[CH:33][CH:32]=[CH:31][CH:30]=5)=[N:26]4)=[CH:21][CH:20]=3)[N:10]=2)[CH2:8]1

참가 물질

4

반응물 1

HCID 11568520HCID 11568520, 화합물

생성물 1

HCID 178511292HCID 178511292, 화합물

시약·촉매·용매 2

HCID 131709914Lindlars catalyst촉매HCID 702Ethanol용매

실험 절차

3-[3-(Azidomethyl)cyclobutyl]-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-8-amine (0.81 mmol, 360 mg) was dissolved in hot ethanol (15 mL) and charged with Lindlar catalyst (0.14 mmol, 362 mg). The reaction mixture was purged with N2, evacuated and filled with H2. The reaction mixture was stirred under H2 for 16 h. The suspension was filtered through celite and the solvent was removed under reduced pressure. Part of the crude material (200 mg out of 300 mg) was purified by silica gel flush chromatography (Jones Flashmaster, 5 g/70 mL cartridge) eluting with 3% MeOH (7 N NH3) in DCM. The final compound was recrystalized from EtOAc and hexane to generate the desired product as a light yellow solid; 1H NMR (400 MHz, CDCl3) δ 8.42-8.41 (m, 1H), 8.27 (dd, J=8.0 Hz, 0.4 Hz, 1H), 8.21-8.19 (m, 2H), 7.95-7.92 (m, 3H), 7.57-7.48 (m, 3H), 7.19 (d, J=4.0 Hz, 1H), 7.11 (d, J=4.0 Hz, 1H), 5.20 (b, 2H), 3.73-3.69 (m, 1H), 2.81 (d, J=7.2 Hz, 2H), 2.66-2.62 (m, 2H), 2.58-2.48 (m, 1H), 2.36-2.30 (m, 2H); MS (ES+): m/z 421.13 (40) [MH+]; HPLC: tR=1.69 min (OpenLynx, polar—5 min).

후처리

  1. customThe reaction mixture was purged with N2
  2. customevacuated
  3. additionfilled with H2
  4. filtrationThe suspension was filtered through celite
  5. customthe solvent was removed under reduced pressure
  6. customPart of the crude material (200 mg out of 300 mg) was purified by silica gel
  7. customflush chromatography (Jones Flashmaster, 5 g/70 mL cartridge)
  8. washeluting with 3% MeOH (7 N NH3) in DCM
  9. customThe final compound was recrystalized from EtOAc and hexane
  10. customHPLC: tR=1.69 min (OpenLynx, polar—5 min)

출처 및 근거

ORD 기록
ord-7f31a20e33b84443b79778f06ab7dee1
출처 데이터셋
uspto-grants-2012_01
특허 번호
US08101613B2

반응 노트

불러오는 중…